These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
302 related articles for article (PubMed ID: 33835396)
1. Update on the Impact of Comorbidities on the Efficacy and Safety of Heart Failure Medications. Chow C; Mentz RJ; Greene SJ Curr Heart Fail Rep; 2021 Jun; 18(3):132-143. PubMed ID: 33835396 [TBL] [Abstract][Full Text] [Related]
2. Reduced Risk of Hyperkalemia During Treatment of Heart Failure With Mineralocorticoid Receptor Antagonists by Use of Sacubitril/Valsartan Compared With Enalapril: A Secondary Analysis of the PARADIGM-HF Trial. Desai AS; Vardeny O; Claggett B; McMurray JJ; Packer M; Swedberg K; Rouleau JL; Zile MR; Lefkowitz M; Shi V; Solomon SD JAMA Cardiol; 2017 Jan; 2(1):79-85. PubMed ID: 27842179 [TBL] [Abstract][Full Text] [Related]
3. Cardiovascular and Renal Outcomes of Mineralocorticoid Receptor Antagonist Use in PARAGON-HF. Jering KS; Zannad F; Claggett B; Mc Causland FR; Ferreira JP; Desai A; Barkoudah E; McMurray JJV; Pfeffer MA; Solomon SD JACC Heart Fail; 2021 Jan; 9(1):13-24. PubMed ID: 33189633 [TBL] [Abstract][Full Text] [Related]
4. Contemporary Treatment Patterns and Clinical Outcomes of Comorbid Diabetes Mellitus and HFrEF: The CHAMP-HF Registry. Vaduganathan M; Fonarow GC; Greene SJ; DeVore AD; Kavati A; Sikirica S; Albert NM; Duffy CI; Hill CL; Patterson JH; Spertus JA; Thomas LE; Williams FB; Hernandez AF; Butler J JACC Heart Fail; 2020 Jun; 8(6):469-480. PubMed ID: 32387066 [TBL] [Abstract][Full Text] [Related]
6. Variation in use and dosing escalation of renin angiotensin system, mineralocorticoid receptor antagonist, angiotensin receptor neprilysin inhibitor and beta-blocker therapies in heart failure and reduced ejection fraction: Association of comorbidities. Albert NM; Tyson RJ; Hill CL; DeVore AD; Spertus JA; Duffy C; Butler J; Patterson JH; Hernandez AF; Williams FB; Thomas L; Fonarow GC Am Heart J; 2021 May; 235():82-96. PubMed ID: 33497697 [TBL] [Abstract][Full Text] [Related]
7. Impact of Individual Patient Profiles on Adherence to Guideline Directed Medical Therapy in Heart Failure With Reduced Ejection Fraction: VCOR-HF Study. Driscoll A; Dinh D; Wong J; Hopper I; Mariani J; Zimmet H; Brennan A; Lefkovits J; Carruthers H; Reid CM Heart Lung Circ; 2020 Dec; 29(12):1782-1789. PubMed ID: 32646638 [TBL] [Abstract][Full Text] [Related]
8. Management of Heart Failure With Reduced Ejection Fraction in Patients With Diabetes Mellitus and Chronic Kidney Disease. Khan MS; Rashid AM; Shafi T; Ferreira JP; Butler J Semin Nephrol; 2023 May; 43(3):151429. PubMed ID: 37871362 [TBL] [Abstract][Full Text] [Related]
9. Mortality, Outcomes, Costs, and Use of Medicines Following a First Heart Failure Hospitalization: EVOLUTION HF. Bozkurt B; Savarese G; Adamsson Eryd S; Bodegård J; Cleland JGF; Khordoc C; Kishi T; Thuresson M; Vardeny O; Zhang R; Lund LH JACC Heart Fail; 2023 Oct; 11(10):1320-1332. PubMed ID: 37354145 [TBL] [Abstract][Full Text] [Related]
10. A review of current key guidelines for managing high-risk patients with diabetes and heart failure and future prospects. Lee MMY; Sattar N Diabetes Obes Metab; 2023 Jul; 25 Suppl 3():33-47. PubMed ID: 37041663 [TBL] [Abstract][Full Text] [Related]
19. Medical treatment of octogenarians with chronic heart failure: data from CHECK-HF. Linssen GCM; Veenis JF; Kleberger A; Grosfeld MJW; Viergever EP; van Dalen BM; de Valk-Bedijn W; Langerveld J; Brunner-La Rocca HP; Hoes AW; Brugts JJ; Clin Res Cardiol; 2020 Sep; 109(9):1155-1164. PubMed ID: 32030498 [TBL] [Abstract][Full Text] [Related]
20. Patient characteristics and initiation of mineralocorticoid receptor antagonists in patients with chronic kidney disease in routine clinical practice in the US: a retrospective cohort study. Blankenburg M; Fett AK; Eisenring S; Haas G; Gay A BMC Nephrol; 2019 May; 20(1):171. PubMed ID: 31096928 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]